Bayer version of COVID-19 antimalarial hopeful may come with quality concerns: report

The U.S. government has grown worried that millions of doses of hydroxychloroquine donated to the U.S. by Bayer for emergency use may have been produced at facilities that didn't meet the FDA's quality standards, sources told Reuters.